Evidence map›Paper›PMID 29343942›Full record

ArticleDrug design, development and therapy2018

Guoyin Zheng, Fengfeng Mo, Chen Ling, Hao Peng, Wei Gu, Min Li, Zhe Chen

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Antioxidants (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. Effects ofIranian journal of basic medical sciences · 2022
    Review
  10. Review
  11. Nutrients · 2022
    Article
  12. Extracts ofChinese herbal medicines · 2022
    Article
  13. Review
  14. Frontiers in nutrition · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Effects ofMolecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Guoyin Zheng *Department of Traditional Chinese Medicine, Changhai Hospital.
Fengfeng Mo *Department of Military Hygiene, Second Military Medical University.
Chen Ling *Department of Biology, School of Life Science, Fudan University, Shanghai, People's Republic of China.
Hao PengDepartment of Traditional Chinese Medicine, Changhai Hospital.
Wei GuDepartment of Traditional Chinese Medicine, Changhai Hospital.
Min LiDepartment of Military Hygiene, Second Military Medical University.
Zhe ChenDepartment of Traditional Chinese Medicine, Changhai Hospital.
Changhai Hospital · CNSecond Military Medical University · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purslane is a widespread succulent herb that exhibits various pharmacological effects. The purpose of this study was to evaluate the protective effect of

Indexed as

PortulacaStreptozocinAnimalsBiomarkersBlood GlucoseChemical and Drug Induced Liver InjuryCytokinesCytoprotectionDiabetes Mellitus, ExperimentalDose-Response Relationship, DrugHypoglycemic AgentsInflammation MediatorsInsulinLipidsLiverMaleBiomarkersBlood GlucoseCytokinesHypoglycemic AgentsInflammation MediatorsInsulinLipidsNF-kappa BPlant Extractsrho-Associated Kinasesrho GTP-Binding ProteinsStreptozocindiabetesliver injuryPortulaca oleracea L.Rho-NFκB

Identifiers

PMID29343942
PMCPMC5749558
OpenAlexW2775899961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.